Rekvina Labs: Surbhit Shah & Others Acquire 49,57,051 Shares
Rekvina Laboratories Ltd has disclosed a substantial acquisition of shares by Surbhit Mukesh Shah and associated individuals (Amit Mukesh Shah, Ami Amit Shah, Krima Surbhit Shah). The acquisition involved 49,57,051 shares, comprising 17,45,490 shares acquired through an Open Offer and 32,11,561 shares via Preferential Allotment. Following this, the total holding of the acquirers and Persons Acting in Concert (PACs) stands at 67,02,541 shares. The acquisition was executed through an Open Offer and a Preferential Allotment, with the latter involving a share swap agreement dated March 16, 2026. The total consideration for the preferential allotment was ₹5,55,78,750, and for the open offer was ₹3,01,40,000.
Key Highlights
- Surbhit Mukesh Shah and PACs acquired 49,57,051 shares in Rekvina Laboratories.
- Acquisition was a mix of Open Offer and Preferential Allotment.
- Total post-acquisition holding for acquirers and PACs is 67,02,541 shares.
- Preferential allotment involved share swap; Open Offer consideration was ₹3.01 Cr.
- The filing is a disclosure under SEBI (SAST) Regulations, 2011.
Price Impact
More from VINRKLB